A clinical trial to study the effect of trial drug MATHIYOOSHNA RASAYANAM(Internal),NYMPATHY THYLAM(External)on UTHIRAVATHA SURONITHAM (Rheumatoid Arthritis).
Phase 2
- Conditions
- Health Condition 1: null- Pain in all major and minor joints swelling of jointsmorning stiffness more then one hour
- Registration Number
- CTRI/2018/02/012040
- Lead Sponsor
- Dr S Neelavathi
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Symmetrical joint involvement
Arthritis of 3 or more joints.
Rheumatoid factor positive or negative
Morning stiffness.
Swelling especially in the inter phalangeal joint.
Patients who are willing for admission and stay in IPD for 40 days or willing to attend OPD
Patient who is willing to undergo radiological investigation and give blood and urine samples for laboratory investigation.
Patient willing to sign the informed consent stating that he/she will consciously stick to the treatment during 40 days but can OPD out of the trial of his/her own conscious discretion.
Exclusion Criteria
Systemic illness
Pregnancy and lactation
History of trauma
Neurological disorder
Tubercular arthritis
Any other serious illness
Psoriatic arthritis
Gouty arthritis
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reducing the pain and weaknessTimepoint: 40 days
- Secondary Outcome Measures
Name Time Method Evaluation of Siddha Diagnostic ParametersTimepoint: 40 days